This Avalo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Avi Kapoor 6 months ago
NewsInitiationPre-Market OutlookMarketsAnalyst RatingsTrading Ideas
Wall Street analysts have changed outlooks on top stocks. For details on changes, check out analyst ratings page. See what analysts think of AVTX.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Mizuho analyst Dan Dolev initiated coverage on PayPay Corp – ADR (NASDAQ:PAYP) with an Outperform rating and announced a price target of $26. PayPay shares closed at $21.02 on Thursday. See how other analysts view this stock.
- Citizens analyst Jason Butler initiated coverage on Avalo Therapeutics Inc (NASDAQ:AVTX) with a Market Outperform rating and announced a price target of $52. Avalo Therapeutics shares closed at $17.76 on Thursday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Heiko Ihle initiated coverage on Atlas Critical Minerals Corp (NASDAQ:ATCX) with a Buy rating and announced a price target of $13.75. Atlas Critical Minerals shares closed at $5.69 on Thursday. See how other analysts view this stock.
- Wells Fargo analyst Colin Langan initiated coverage on Versigent PLC (NYSE:VGNT) with an Overweight rating and announced a price target of $35. Versigent shares closed at $28.10 on Thursday. See how other analysts view this stock.
- Benchmark analyst Mark Palmer initiated coverage on PayPay Corp – ADR (NASDAQ:PAYP) with a Buy rating and announced a price target of $31. PayPay shares closed at $21.02 on Thursday. See how other analysts view this stock.
Considering buying AVTX stock? Here’s what analysts think:
Photo via Shutterstock